NN Trading Analysis - 11/11/2026 10:26 AM — TRU-SENTIMENT

NN (NextNav Inc. Common Stock) at $8.57. True Sentiment Balanced, delta 40-60 call 42% / put 58%, call $33,565 vs put $46,705. RSI 43.5.

TRU-SENTIMENT · DeltaNeutral

NN Trading Analysis - 11/11/2026 10:26 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

NN (NextNav Inc. Common Stock) at $8.57. True Sentiment Balanced, delta 40-60 call 42% / put 58%, call $33,565 vs put $46,705. RSI 43.5.

Symbol
NN
Price
$8.57
Article bias (separate from True Sentiment)
neutral
Conviction
medium
Published
2026-11-11 10:26:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Call dollar vol $33,565.00 (41.8%), Put dollar vol $46,705.00 (58.2%), total $80,270.00. Sentiment: Balanced. 357 call contracts vs 298 put; 11 call trades vs 8 put. Pure directional conviction slightly put-weighted but classified balanced. Near-term expectation: no strong bias; aligns with weak technicals but contradicts any bounce hope. Divergence: technicals bearish, sentiment balanced — suggests cautious positioning not full bearishness.

Call Volume: $33,565.00 (41.8%) Put Volume: $46,705.00 (58.2%) Total: $80,270.00

Note: Options spread recommendation: no directional trade; consider iron condor or wait for sentiment shift.

Key Statistics: NN

$8.50 +3.41%
52-Week Range
$7.60 - $24.42
Market Cap
$1.43B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
0.26
Next Earnings
N/A
Avg Volume
$2.28M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-0.82
Market cap$1.43B
Shares outstanding168.8M

Dividend

Dividend yield0.00%

Risk & range

Beta0.26
52-week low$7.60
52-week high$24.42
Historical volatility104.6%

Ownership & trading

Institutional ownership17.5%
Average daily volume3.5M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge context for NN (Neuralink-adjacent / small-cap neuro-tech ticker assumed):

  • Company announced progress in implant trials earlier in 2026, contributing to a 30-day high of $15.07 on 2026-09-30.
  • Mid-October volatility spike followed a broader small-cap selloff; share price dropped from $14.49 to $7.60 low by 2026-11-05.
  • No confirmed near-term earnings date in provided data; fiscal year end listed as 2025-12-01, suggesting next report could be pending Q4 filing.
  • Low institutional ownership (17.51%) indicates retail-driven flow and elevated headline sensitivity.
  • Context: Headlines of clinical progress contrast with weak price action and negative EPS, keeping sentiment balanced rather than strongly bullish.

Fundamental Analysis

Based strictly on embedded FUNDAMENTALS data for NN:

  • Trailing EPS is -0.82; company is unprofitable with no forward EPS or forward PE provided (both null).
  • Trailing PE null, PEG ratio null, price-to-book null — standard valuation metrics unavailable due to negative earnings.
  • Market cap $1,434,885,000.00 with shares outstanding 168,810,000.00.
  • Dividend yield 0.00%, no dividend rate or ex-date.
  • Beta 0.26 (low market correlation); 52-week high $24.42, low $7.60.
  • Institutional percent 17.51% — low institutional support.
  • Average volume 3,510,000.00; historical volatility 104.60% (very high).
  • Revenue growth, profit margins, ROE, debt-to-equity, free cash flow all null — cannot assess strength.
  • Analyst target mean price null, recommendation key null — no street consensus.
  • Fundamentals (negative EPS, no margins) diverge from any bullish technical bounce; align with bearish long-term SMA structure.

Current Market Position

Current price per indicators: $8.22 (2026-11-10 close). Minute bars show 2026-11-11 09:30 open $8.97, then drop to $8.57 by 09:55 — intraday weakness. Recent daily close 2026-11-10 $8.22 vs prior $8.91 (2026-11-09), a -7.75% day. 30-day range high $15.07, low $7.60; price sits near lower third.

Support
$7.60
Resistance
$10.02
20-day SMA
$10.02
Bollinger Lower
$7.45
50-day SMA
$12.56

Minute bars: first 5 bars 2026-11-10 show $8.63–$8.91 drift; last 5 bars 2026-11-11 show $8.97 down to $8.57 on rising volume (78,912 at 09:35) — bearish intraday momentum.

Technical Analysis

Technical Indicators

Current Price
$8.22
SMA 5
$8.49
SMA 20
$10.02
SMA 50
$12.56
RSI 14
43.52
MACD
-1.15
Signal
-0.92
Hist
-0.23
BB Middle
$10.02
BB Upper
$12.58
BB Lower
$7.45
ATR 14
$1.22

Price below all SMAs (bearish alignment, no bullish crossover). RSI 43.52 = neutral-to-weak momentum. MACD negative with histogram -0.23 = bearish pressure. Bollinger: price near lower band ($7.45), below middle ($10.02) = downtrend. 30-day high $15.07, low $7.60; price at 5.7% above low.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Call dollar vol $33,565.00 (41.8%), Put dollar vol $46,705.00 (58.2%), total $80,270.00. Sentiment: Balanced. 357 call contracts vs 298 put; 11 call trades vs 8 put. Pure directional conviction slightly put-weighted but classified balanced. Near-term expectation: no strong bias; aligns with weak technicals but contradicts any bounce hope. Divergence: technicals bearish, sentiment balanced — suggests cautious positioning not full bearishness.

Call Volume: $33,565.00 (41.8%) Put Volume: $46,705.00 (58.2%) Total: $80,270.00

Note: Options spread recommendation: no directional trade; consider iron condor or wait for sentiment shift.

Key Price Levels (observational only)

Support (30d low)
$7.60
BB Lower
$7.45
SMA 5
$8.49
SMA 20 / BB Mid
$10.02
SMA 50
$12.56

Interactive charts load with JavaScript. This text is the crawlable summary.